Insider trade

Alkermes (ALKS): Officer exercised options on 5,000 units

Craig C. Hopkinson, Officer at Alkermes, reported an option exercise of 5,000 units.

5,000
Derivative units
Traded
Jan 8, 2026
Filed
Jan 8, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Nov 18, 2025Company filing · Form 8-K · Material agreement, New debtSigned an important agreement, and took on new debt or obligations (and 1 more item)
  2. Dec 1, 2025InsiderOfficer sold ~$117K of ALKS shares in the open market
  3. Dec 3, 2025InsiderOfficer sold ~$112K of ALKS shares in the open market
  4. Jan 2, 2026InsiderOfficer sold ~$112K of ALKS shares in the open market
  5. Jan 8, 2026InsiderOfficer sold ~$150K of ALKS shares in the open market

What came next

  1. Jan 12, 2026Company filing · Form 8-K · Results, Reg FDReported its results, and shared information with investors
  2. Feb 2, 2026Insider · 2 peopleInsiders: 4 sales (~$2.4M)
  3. Feb 12, 2026Company filing · Form 8-K · Material agreement, Agreement endedCompleted buying or selling a business or assets, and signed an important agreement (and 3 more items)“On February 12, 2026, the Company and Avadel Pharmaceuticals plc (“Avadel”), completed the transactions contemplated by the previously announced Transaction Agreement (the “Original Transaction Agreement”) dated October 22, 2025, as amended by Amendment No.1 to the Transaction Agreement (the “Amendment”) dated November 18, 2025, by and between the Company and Avadel (as amended, the “Transaction Agreement”).”
  4. Feb 24, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On February 24, 2026, Richard F. Pops, Chairman and Chief Executive Officer of Alkermes plc (the “Company”), notified the Company’s board of directors (the “Board”) of his decision to retire from his position of Chief Executive Officer, effective July 31, 2026, following a distinguished 35 years of service in this role.”
  5. Feb 25, 2026Company filing · Form 8-K · ResultsReported its results
  6. Mar 2, 2026Insider · 4 peopleInsiders: 4 sales (~$709K)
  7. Mar 3, 2026InsiderOfficer sold ~$61K of ALKS shares in the open market
  8. Apr 1, 2026InsiderOfficer sold ~$320K of ALKS shares in the open market
  9. Apr 6, 2026InsiderOfficer sold ~$70K of ALKS shares in the open market
  10. May 1, 2026InsiderOfficer sold ~$301K of ALKS shares in the open market
  11. May 4, 2026InsiderOfficer sold ~$68K of ALKS shares in the open market
  12. May 5, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Alkermes

For Alkermes, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 2 Congress trade reports dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its ALKS page.

Other recent filings by Craig C. Hopkinson, EVP R&D, Chief Medical Officer

The full history of Craig C. Hopkinson, EVP R&D, Chief Medical Officer is on the profile page.

How this filing works

Explore the data

Common questions

Which Alkermes (ALKS) insider traded, and how much?

Craig C. Hopkinson, Officer at Alkermes, reported an option exercise of 5,000 units. Not an open-market trade.

When did it happen, and when was it made public?

Traded: Jan 8, 2026. Filed: Jan 8, 2026.

Is the dollar amount exact?

It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.

Where does this information come from?

From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Alkermes recently?

For Alkermes, OQRO holds 6 insider filings (SEC Form 4 or Form 144) and 2 Congress trade reports dated in the last 90 days. They are listed on the ALKS page.

Does this mean ALKS stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Alkermes

Everything OQRO holds on this company is on its ALKS page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data